Europe Skin Cancer Diagnostics Market Size & Outlook
Related Markets
Europe skin cancer diagnostics market highlights
- The Europe skin cancer diagnostics market generated a revenue of USD 2,855.4 million in 2024.
- The market is expected to grow at a CAGR of 6.3% from 2025 to 2033.
- In terms of segment, non-melanoma was the largest revenue generating cancer type in 2024.
- Non-Melanoma is the most lucrative cancer type segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2025 to 2033.
Europe data book summary
| Market revenue in 2024 | USD 2,855.4 million |
| Market revenue in 2033 | USD 4,912.1 million |
| Growth rate | 6.3% (CAGR from 2025 to 2033) |
| Largest segment | Non-melanoma |
| Fastest growing segment | Non-Melanoma |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Melanoma, Non-Melanoma |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.8% of the global skin cancer diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,614.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Skin Cancer Diagnostics Market Scope
Skin Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| NeoGenomics Laboratories, Inc. | View profile | - | - | - |
| DermaSensor | View profile | 11-50 | Miami, Florida, United States, North America | https://www.dermasensor.com.au |
| SkylineDx | View profile | 11-50 | Rotterdam, Zuid-Holland, The Netherlands, Europe | http://www.skylinedx.com/ |
| Quest Diagnostics Incorporated | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| DermTech Inc | View profile | 208 | 12340 El Camino Real, San Diego, CA, United States, 92130 | https://www.dermtech.com |
| Foundation Medicine | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | http://www.foundationmedicine.com |
Europe skin cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to skin cancer diagnostics market will help companies and investors design strategic landscapes.
Non-melanoma was the largest segment with a revenue share of 79.61% in 2024. Horizon Databook has segmented the Europe skin cancer diagnostics market based on melanoma, non-melanoma covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Europe skin cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe skin cancer diagnostics market databook
-
Our clientele includes a mix of skin cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe skin cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe skin cancer diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Europe skin cancer diagnostics market size, by country, 2021-2033 (US$M)
Europe Skin Cancer Diagnostics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
